Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Background

Recent literatures indicate that maternal hormone exposure is a risk factor for autism spectrum disorder (ASD). We hypothesize that prenatal progestin exposure may counteract the neuroprotective effect of estrogen and contribute to ASD development, and we aim to develop a method to ameliorate prenatal progestin exposure-induced autism-like behavior.

Methods

Experiment 1: Prenatal progestin exposure-induced offspring are treated with resveratrol (RSV) through either prenatal or postnatal exposure and then used for autism-like behavior testing and other biomedical analyses. Experiment 2: Prenatal norethindrone (NET) exposure-induced offspring are treated with ERβ knockdown lentivirus together with RSV for further testing. Experiment 3: Pregnant dams are treated with prenatal NET exposure together with RSV, and the offspring are used for further testing.

Results

Eight kinds of clinically relevant progestins were used for prenatal exposure in pregnant dams, and the offspring showed decreased ERβ expression in the amygdala with autism-like behavior. Oral administration of either postnatal or prenatal RSV treatment significantly reversed this effect with ERβ activation and ameliorated autism-like behavior. Further investigation showed that RSV activates ERβ and its target genes by demethylation of DNA and histone on the ERβ promoter, and then minimizes progestin-induced oxidative stress as well as the dysfunction of mitochondria and lipid metabolism in the brain, subsequently ameliorating autism-like behavior.

Conclusions

We conclude that resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation. Our data suggest that prenatal progestin exposure is a strong risk factor for autism-like behavior. Many potential clinical progestin applications, including oral contraceptive pills, preterm birth drugs, and progestin-contaminated drinking water or seafood, may be risk factors for ASD. In addition, RSV may be a good candidate for clinically rescuing or preventing ASD symptoms in humans, while high doses of resveratrol used in the animals may be a potential limitation for human application.

Electronic supplementary material

The online version of this article (10.1186/s13229-018-0225-5) contains supplementary material, which is available to authorized users.

Related collections

Most cited references 46

Record: found
Abstract: found
Article: not found

Advances in autism genetics: on the threshold of a new neurobiology.

Brett Abrahams, Daniel Geschwind (2008)

Autism is a heterogeneous syndrome defined by impairments in three core domains: social interaction, language and range of interests. Recent work has led to the identification of several autism susceptibility genes and an increased appreciation of the contribution of de novo and inherited copy number variation. Promising strategies are also being applied to identify common genetic risk variants. Systems biology approaches, including array-based expression profiling, are poised to provide additional insights into this group of disorders, in which heterogeneity, both genetic and phenotypic, is emerging as a dominant theme.

0 comments Cited 519 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: found

Is Open Access

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures

D Rossignol, R Frye (2011)

Recent studies have implicated physiological and metabolic abnormalities in autism spectrum disorders (ASD) and other psychiatric disorders, particularly immune dysregulation or inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures (‘four major areas'). The aim of this study was to determine trends in the literature on these topics with respect to ASD. A comprehensive literature search from 1971 to 2010 was performed in these four major areas in ASD with three objectives. First, publications were divided by several criteria, including whether or not they implicated an association between the physiological abnormality and ASD. A large percentage of publications implicated an association between ASD and immune dysregulation/inflammation (416 out of 437 publications, 95%), oxidative stress (all 115), mitochondrial dysfunction (145 of 153, 95%) and toxicant exposures (170 of 190, 89%). Second, the strength of evidence for publications in each area was computed using a validated scale. The strongest evidence was for immune dysregulation/inflammation and oxidative stress, followed by toxicant exposures and mitochondrial dysfunction. In all areas, at least 45% of the publications were rated as providing strong evidence for an association between the physiological abnormalities and ASD. Third, the time trends in the four major areas were compared with trends in neuroimaging, neuropathology, theory of mind and genetics (‘four comparison areas'). The number of publications per 5-year block in all eight areas was calculated in order to identify significant changes in trends. Prior to 1986, only 12 publications were identified in the four major areas and 51 in the four comparison areas (42 for genetics). For each 5-year period, the total number of publications in the eight combined areas increased progressively. Most publications (552 of 895, 62%) in the four major areas were published in the last 5 years (2006–2010). Evaluation of trends between the four major areas and the four comparison areas demonstrated that the largest relative growth was in immune dysregulation/inflammation, oxidative stress, toxicant exposures, genetics and neuroimaging. Research on mitochondrial dysfunction started growing in the last 5 years. Theory of mind and neuropathology research has declined in recent years. Although most publications implicated an association between the four major areas and ASD, publication bias may have led to an overestimation of this association. Further research into these physiological areas may provide insight into general or subset-specific processes that could contribute to the development of ASD and other psychiatric disorders.

0 comments Cited 216 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate.

Dario Valenzano, Eva Terzibasi, Tyrone Genade … (2006)

Resveratrol, a natural phytoalexin found in grapes and red wine, increases longevity in the short-lived invertebrates Caenorhabditis elegans and Drosophila and exerts a variety of biological effects in vertebrates, including protection from ischemia and neurotoxicity. Its effects on vertebrate lifespan were not yet known. The relatively long lifespan of mice, which live at least 2.5 years, is a hurdle for life-long pharmacological trials. Here, the authors used the short-lived seasonal fish Nothobranchius furzeri with a maximum recorded lifespan of 13 weeks in captivity. Short lifespan in this species is not the result of spontaneous or targeted genetic mutations, but a natural trait correlated with the necessity to breed in an ephemeral habitat and tied with accelerated development and expression of ageing biomarkers at a cellular level. Resveratrol was added to the food starting in early adulthood and caused a dose-dependent increase of median and maximum lifespan. In addition, resveratrol delays the age-dependent decay of locomotor activity and cognitive performances and reduces the expression of neurofibrillary degeneration in the brain. These results demonstrate that food supplementation with resveratrol prolongs lifespan and retards the expression of age-dependent traits in a short-lived vertebrate.

0 comments Cited 200 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Contributors

Haijia Chen: +86-13922736688 , chenhaijia@saliai.com

Wei Xiang: +86-18608981299 , xiangwei8@163.com

Paul Yao:

ORCID: http://orcid.org/0000-0001-9407-0779

+86-13049687987 , vasilis112@yahoo.com

Journal

Journal ID (nlm-ta): Mol Autism

Journal ID (iso-abbrev): Mol Autism

Title: Molecular Autism

Publisher: BioMed Central (London )

ISSN (Electronic): 2040-2392

Publication date (Electronic): 2 August 2018

Publication date PMC-release: 2 August 2018

Publication date Collection: 2018

Volume: 9

Electronic Location Identifier: 43

Affiliations

[1 ]ISNI 0000 0001 2331 6153, GRID grid.49470.3e, Institute of Rehabilitation Center, , Tongren Hospital of Wuhan University, ; Wuhan, 430060 People’s Republic of China

[2 ]SALIAI Stem Cell Institute of Guangdong, Guangzhou SALIAI Stem Cell Science and Technology Co. LTD, Guangzhou, 510055 People’s Republic of China

[3 ]GRID grid.459758.2, Department of Pediatrics, , Hainan Maternal and Child Health Hospital, ; Haikou, 570206 People’s Republic of China

Author information

Paul Yao http://orcid.org/0000-0001-9407-0779

Article

Publisher ID: 225

DOI: 10.1186/s13229-018-0225-5

PMC ID: 6090838

PubMed ID: 30123446

SO-VID: 70c15d77-ce3b-4265-b750-1fb867c2531d

License:

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

History

Date received : 5 February 2018

Date accepted : 19 July 2018

Funding

Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;

Award ID: 81772097

Custom metadata

ScienceOpen disciplines: Neurosciences

Keywords: autism spectrum disorder,estrogen receptor β,lipid metabolism,mitochondria,oxidative stress,progestin,resveratrol

Data availability:

ScienceOpen disciplines: Neurosciences

Keywords: autism spectrum disorder, estrogen receptor β, lipid metabolism, mitochondria, oxidative stress, progestin, resveratrol

Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation

Read this article at

Abstract

Background

Methods

Results

Conclusions

Electronic supplementary material

Related collections

The Dynamic Brain

Most cited references 46

Advances in autism genetics: on the threshold of a new neurobiology.

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures

Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate.

Author and article information

Contributors

Journal

Affiliations

Author information

Article

History

Funding

Categories

Custom metadata

Comments

Comment on this article

Similar content 836

Cited by 26

Most referenced authors 910